NCT00502320View on ClinicalTrials.gov

Ramelteon in the Treatment of Sleep and Mood in Patients With Seasonal Affective Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

July 31, 2008

Conditions
Seasonal Affective Disorder
Interventions
DRUG

Ramelteon

one 8 mg tablet at bed for up to 4 months

DRUG

Placebo

one tablet at bedtime for up to 4 months

Trial Locations (1)

18103

Lehigh Valley Hospital, Department of Psychiatry, Allentown

All Listed Sponsors
collaborator

Takeda Pharmaceuticals North America, Inc.

INDUSTRY

lead

Lehigh Valley Hospital

OTHER

NCT00502320 - Ramelteon in the Treatment of Sleep and Mood in Patients With Seasonal Affective Disorder | Biotech Hunter | Biotech Hunter